Crowdonomics
This isn’t Med-X, Inc.’s most recent raise. Reg A+ · Equity · May 2025 (Open) is more current.View latest round
Med-X, Inc.

Reg CF · Common Stock · May 2020

ClosedReg CFCommon Equity
via truCrowd, Inc · last checked Sep 24, 2026
Raised
$0 / $1.1M max
0% of ceiling
Investors
—
—
Estimated pre-money
$88.6M
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Amendments to this offering

6 amendments
  1. Jun 1, 2021
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Mar 1, 2021
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  3. Nov 30, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  4. Nov 2, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  5. Aug 31, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  6. Jul 31, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Est. pre-money$88.6M
Price / share$0.80
Price / share today$768.00
Shares offered12,500

Estimated, not stated: $0.80 × 110,690,966 securities outstanding as of Dec 31, 2019 (Form 1-K filed May 19, 2020, p. 1).

$0.80 as sold; $768.00 after the Oct 2022 split (1:60) and the Apr 2024 split (1:16) (Form 1-K, p. 1).

Offering details

Target$10,000
Max$1,070,000
Min investment—
OpenedMay 21, 2020
DeadlineSep 10, 2021
Days active2,333

Links & provenance

Source: SEC EDGAR
0001620704-20-000002
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.